“Drugmakers including Bristol-Myers Squibb Co., Pfizer Inc. (PFE) and Eli Lilly & Co. (LLY) have spent billions of dollars on ineffective therapies in a so-far fruitless effort to come up with a treatment for dementia and Alzheimer’s. Now, in the latest of a steady drumbeat of research that suggests diet, exercise and socializing remain patients’ best hope, a study published today in the Proceedings of the National Academy of Sciences shows that vitamins B6 and B12 combined with folic acid slowed atrophy of gray matter in brain areas affected by Alzheimer’s disease.”
Related posts:
U.S. to buy $170M in meat, fish to help farms hit by drought
U.S. ex-DEA agent in unlikely new role with pot investment firm
Banker feted as next 'Snowden' for selling stolen tax data to governments
On Obama’s Plan, a Message Emerges in Israel: Stay Quiet
ZenoRadio, a Poor Man's Pandora, Is Booming
Rising incomes fuel India’s growing appetite for meat
Chinese Hackers Could Face Aggressive Action From U.S. Over Cyber Attacks
Taliban Behead 17 for Singing and Dancing
Last flight for US-funded air war on drugs as Colombia counts health cost
Study: Level of military substance abuse now a 'public health crisis,' Pentagon care outdated
Drone owners must register with FAA, starting December 21
As Inventor of Subprime Car Loans Exits, Critics Smell a Lemon
Oklahoma tornado victims denied permits to rebuild their homes
Israeli court rules military not at fault in US activist’s death
401(k) millionaires are bragging and posting their balances to social media